Theoretical model of critical issues in informed consent in HIV vaccine trials
- PMID: 24865892
- PMCID: PMC4122591
- DOI: 10.1080/09540121.2014.920074
Theoretical model of critical issues in informed consent in HIV vaccine trials
Abstract
The informed consent process (ICP) for HIV vaccine trials poses unique challenges and would benefit from improvements to its historically based structure and format. Here, we propose a theoretical framework that provides a basis for systematically evaluating and addressing these challenges. The proposed framework follows a linear pathway, starting with the precondition of voluntariness, three main variables of valid decision-making (competency, provision of information and understanding) and then the consequential outcome of either refusal or consent to participate. The existing literature reveals that culturally appropriate provision of information and resultant understanding by the vaccine trial participant are among the most significant factors influencing the authenticity of valid decision-making, though they may be overridden by other considerations, such as individual altruism, mistrust, and HIV-related stigma. Community collaborations to foster bidirectional transmission of information and more culturally tailored consenting materials, therefore, represent a key opportunity to enhance the ICP. By providing a visual synopsis of the issues most critical to IC effectiveness in a categorical and relational manner, the framework provided here presents HIV vaccine researchers a tool by which the ICP can be more systematically evaluated and consequently improved.
Keywords: HIV; HIV vaccine; HIV vaccine trials; informed consent; theoretical models.
Figures
Similar articles
-
HIV vaccine trials: critical issues in informed consent.S Afr J Sci. 2000 Jun;96:313-7. S Afr J Sci. 2000. PMID: 15739286
-
Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study.BMC Med Ethics. 2024 Mar 13;25(1):29. doi: 10.1186/s12910-024-01033-z. BMC Med Ethics. 2024. PMID: 38481301 Free PMC article.
-
Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials.J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):161-9. doi: 10.1097/00126334-200302010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 12571526 Clinical Trial.
-
Taking informed consent seriously in global HIV vaccine research.J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):117-23. doi: 10.1097/00126334-200302010-00001. J Acquir Immune Defic Syndr. 2003. PMID: 12571519 Review. No abstract available.
-
Preparedness for AIDS vaccine trials in India.Indian J Med Res. 2008 Jun;127(6):531-8. Indian J Med Res. 2008. PMID: 18765870 Review.
References
-
- Kahn P, editor. AIDS vaccine handbook: Global Perspectives. AIDS Vaccine Advocacy Coalition; New York, NY: 2005.
-
- Lidz CW. Informed consent: a critical part of modern medical research. The American journal of the medical sciences. 2011 Oct;342(4):273–275. - PubMed
-
- Mariner WK. Taking informed consent seriously in global HIV vaccine research. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):117–123. - PubMed
-
- Henderson GE. Is informed consent broken? The American journal of the medical sciences. 2011 Oct;342(4):267–272. - PubMed
-
- Faden RF, Beauchamp TL. A History and Theory of Informed Consent. Oxford University Press; New York, NY: 1986. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical